v2.3.0.11
Financial Instruments Assets and Liabilities Measured on Recurring Basis (Detail) (USD $)
Jul. 03, 2011
Dec. 31, 2010
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial assets measured at fair value on a recurring basis $ 32,352,000,000 [1] $ 35,544,000,000 [1]
Other selected financial assets:    
Held-to-maturity debt securities, carried at amortized cost 781,000,000 [2] 1,178,000,000 [2]
Private equity securities, carried at cost or equity method 1,046,000,000 1,134,000,000
Short-term loans, carried at cost 462,000,000 467,000,000
Long-term loans, carried at cost 182,000,000 299,000,000
Total 2,471,000,000 [3] 3,078,000,000 [3]
Total selected financial assets 34,823,000,000 [4] 38,622,000,000 [4]
Financial instruments measured at fair value on a recurring basis:    
Financial liabilities measured at fair value on a recurring basis 938,000,000 [1] 884,000,000 [1]
Other financial liabilities:    
Short-term borrowings, carried at historical proceeds, as adjusted 5,988,000,000 [3] 5,603,000,000 [3]
Long-term debt, carried at historical proceeds, as adjusted 35,723,000,000 [5],[6] 38,410,000,000 [5],[6]
Total 41,711,000,000 44,013,000,000
Fair value of long term debt 39,200,000,000 42,300,000,000
Total selected financial liabilities 42,649,000,000 44,897,000,000
Trading securities [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial assets measured at fair value on a recurring basis 157,000,000 173,000,000
Available - for - sale debt securities [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial assets measured at fair value on a recurring basis 29,558,000,000 [2] 32,699,000,000 [2]
Available - for - sale money market funds [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial assets measured at fair value on a recurring basis 1,141,000,000 1,217,000,000
Available - for - sale equity securities, excluding money market funds [Member]
   
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial assets measured at fair value on a recurring basis 327,000,000 [2] 230,000,000 [2]
Interest rate swaps [Member]
   
Financial instruments measured at fair value on a recurring basis:    
Financial liabilities measured at fair value on a recurring basis 5,000,000 [7] 4,000,000 [7]
Derivative assets measured at fair value on a recurring basis 609,000,000 [8] 603,000,000 [8]
Foreign Exchange Contract [Member]
   
Financial instruments measured at fair value on a recurring basis:    
Financial liabilities measured at fair value on a recurring basis 540,000,000 [7] 623,000,000 [7]
Derivative assets measured at fair value on a recurring basis 457,000,000 [8] 128,000,000 [8]
Footnotes to selected financial assets and liabilities [Abstract]    
Instruments used as offsets (assets) 107,000,000 17,000,000
Instruments used as offsets (liabilities) 1,000,000 93,000,000
Foreign currency forward-exchange contracts [Member]
   
Financial instruments measured at fair value on a recurring basis:    
Financial liabilities measured at fair value on a recurring basis 393,000,000 [7] 257,000,000 [7]
Derivative assets measured at fair value on a recurring basis 103,000,000 [8] 494,000,000 [8]
Footnotes to selected financial assets and liabilities [Abstract]    
Instruments used as offsets (assets) 73,000,000 326,000,000
Instruments used as offsets (liabilities) 41,000,000 186,000,000
Fair value inputs Level 1 [Member]
   
Footnotes to selected financial assets and liabilities [Abstract]    
Available - for - sale equity securities, excluding money market funds 111,000,000 105,000,000
Fair value inputs Level 3 [Member]
   
Footnotes to selected financial assets and liabilities [Abstract]    
Available - for - sale equity securities, excluding money market funds 48,000,000  
Foreign Currency Debt Designated As Hedging Instruments Long Term Liability At Fair Value [Member]
   
Other financial liabilities:    
Long-term debt, carried at historical proceeds, as adjusted $ 881,000,000 $ 880,000,000
[1] Fair values are determined based on valuation techniques categorized as follows: Level 1 means the use of quoted prices for identical instruments in active markets; Level 2 means the use of quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active or are directly or indirectly observable; Level 3 means the use of unobservable inputs. All of our financial assets and liabilities measured at fair value on a recurring basis use Level 2 inputs in the calculation of fair value, except that included in available-for-sale equity securities, excluding money market funds, are $111 million as of July 3, 2011 and $105 million as of December 31, 2010 of investments that use Level 1 inputs in the calculation of fair value, and $48 million that use Level 3 inputs as of July 3, 2011.
[2] Gross unrealized gains and losses are not significant.
[3] The differences between the estimated fair values and carrying values of our financial assets and liabilities not measured at fair value on a recurring basis were not significant at July 3, 2011 or December 31, 2010.
[4] The decrease in selected financial assets is primarily due to redemptions of investments, the proceeds from which were used to fund our acquisition of King (see Note 3. Acquisition of King Pharmaceuticals, Inc.)
[5] Includes foreign currency debt with fair values of $881 million at July 3, 2011 and $880 million at December 31, 2010, which are used to hedge the exposure of certain foreign currency denominated net investments.
[6] The fair value of our long-term debt is $39.2 billion at July 3, 2011 and $42.3 billion at December 31, 2010.
[7] Designated as hedging instruments, except for certain foreign currency contracts used as offsets; namely, foreign currency forward-exchange contracts with fair values of $41 million and foreign currency swaps with fair values of $1 million at July 3, 2011; and foreign currency forward-exchange contracts with fair values of $186 million and foreign currency swaps with fair values of $93 million at December 31, 2010.
[8] Designated as hedging instruments, except for certain foreign currency contracts used as offsets; namely, foreign currency swaps with fair values of $107 million and foreign currency forward-exchange contracts with fair values of $73 million at July 3, 2011; and foreign currency forward-exchange contracts with fair values of $326 million and foreign currency swaps with fair values of $17 million at December 31, 2010.